SCHEMBL29942167

SCHEMBL29942167

CCOC(=O)c1cc2ccnc(C3=CCN(C(=O)OC(C)(C)C)CC3)c2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.46
▸ GRM1 Q13255 7/20 0.46
▸ GRM5 P41594 7/20 0.46
▸ CDK9 P50750 3/20 0.43
▸ CCNT1 O60563 1/20 0.43
▸ JAK1 P23458 1/20 0.43
▸ TNK2 Q07912 2/20 0.42
▸ WNT3A P56704 1/20 0.42
▸ GPR119 Q8TDV5 1/20 0.41
▸ PDK4 Q16654 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23756602 1.00 PDE10A (0.46) PDE10AGRM1GRM5CDK9CCNT1
SCHEMBL30122546 0.90 PDE10A (0.39) PDE10AGRM1GRM5CDK9CCNT1
SCHEMBL25581555 0.88 PDE10A (0.49) PDE10AGRM1GRM5CDK9CCNT1
SCHEMBL29942289 0.84 PDK4 (0.52) GRM1GRM5CDK9CCNT1JAK1
SCHEMBL23756013 0.84 PDK4 (0.52) GRM1GRM5CDK9CCNT1JAK1
SCHEMBL29942132 0.80 CDK9 (0.44) GRM1GRM5CDK9CCNT1JAK1
SCHEMBL23755478 0.80 CDK9 (0.44) GRM1GRM5CDK9CCNT1JAK1
SCHEMBL17109184 0.80 KDM4E (0.52) JAK1PDE4B
SCHEMBL23755847 0.78 HPGD (0.51) JAK1GPR119
SCHEMBL29941903 0.78 HPGD (0.51) JAK1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115348961-B Heterocyclic PAD4 inhibitors 百时美施贵宝公司 2025-03-04 — — CN disclosed
EP-4103559-A1 HETEROCYCLIC PAD4 INHIBITORS Bristol-Myers Squibb Company (US) 2022-12-21 — — EP disclosed
CN-115348961-A Heterocyclic PAD4 inhibitors 百时美施贵宝公司 2022-11-15 — — CN disclosed
Send feedback